Max Robotics — Global Service Robot Directory + US Certification

About

Carly Griffin is a leading figure in functional genomics and antibody engineering, best known for her pioneering work in developing high-throughput platforms for recombinant antibody discovery. Her landmark 2015 study, cited over 120 times, introduced an industrialized pipeline to generate validated recombinant antibodies against 346 transcription factors—a critical advance that transformed these essential reagents from limited commercial sources into permanent, renewable resources. This work has had profound implications for systems biology, enabling researchers to systematically probe protein expression and interactions at scale. Griffin’s contributions bridge the gap between genomics and proteomics, providing the tools necessary to decode complex regulatory networks. Her platform has become a gold standard in the field, accelerating discoveries in gene regulation and disease mechanisms. Beyond her technical innovations, Griffin is recognized for fostering open-science practices, making validated antibodies widely accessible to the research community. Her achievements underscore a career dedicated to democratizing high-quality reagents and empowering scientists to tackle fundamental questions in molecular biology.